Evaluating the Efficacy of a 91-day Self-talk Mental Health Self-care Journal

Sponsor
University of Victoria (Other)
Overall Status
Recruiting
CT.gov ID
NCT05738109
Collaborator
Switch Research (Other), Mathematics of Information Technology and Complex Systems (Other)
70
1
2
7.5
9.3

Study Details

Study Description

Brief Summary

  1. Does a 91-day self-talk journal intervention improve outcomes of self-criticism, self-esteem, automatic negative self-statements, and mental health among participants using the journal over wait-list control?

  2. What is the adherence rate to a 91-day self-talk journal intervention?

  3. What were participants' experience(s) of using a 91-day self-talk journal?

Condition or Disease Intervention/Treatment Phase
  • Other: Self-Talk Journals
N/A

Detailed Description

The following research project can contribute to the investigators' understanding of how/how well self-guided resources can increase participant outcomes of self-criticism, self-esteem, automatic negative self-statements, and mental health. Self-guided resources such as a self-talk journal provide can provide an easily accessible avenue for improving individual mental health. There has been a recent surge in the popularity of health-promotive self-care products, or products aimed at providing individuals with "the knowledge, skills, and attitudes required to achieve and maintain good health". These products (often in the form of journals) are similar to "self-help books"; however, a key difference is that self-care products prompt and provide space for the reader to actively engage in activities and psychological techniques, unlike the passive nature of traditional self-help books. These products typically address mental health concerns (i.e., mental health self-care) and are advertised to provide an effective means for individuals to reduce stress, improve self-compassion, and boost wellbeing. What's more, the generally positive reviews these products garner provides the perception that these products are well-received and effective in eliciting these outcomes. However, the scientific foundation for the majority of these journals is unknown. Furthermore, the efficacy of these products for improving or promoting their intended outcome(s) is often not addressed outside of these, often positive, reviews.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Evaluating the Efficacy of a 91-day Self-talk Mental Health Self-care Journal
Actual Study Start Date :
Sep 13, 2022
Anticipated Primary Completion Date :
Mar 30, 2023
Anticipated Study Completion Date :
Apr 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Self-guided journaling Intervention

Participants assigned to the waitlist group complete a 2wk, 1mo, 2mo and 3mo survey over the 91-day study period. After the 91-days they will also complete a follow-up survey and exit interview

Other: Self-Talk Journals
Participants randomized to the intervention group will receive a physical copy of the 91-day self-talk journal during the baseline meeting. Participants will also be introduced the purpose of the journal and its intended usage (i.e., daily journaling). Intervention participants will not be offered guidance or feedback on the journal after these initial instructions, in order to emulate an ad libitum usage. Control group participants will not receive any contact with the researchers outside of the planned questionnaires and to receive their journal at the three-month timepoint.

No Intervention: Waitlist Control

Participants assigned to the waitlist group complete a 2wk, 1mo, 2mo and 3mo survey over the 91-day study period. After the 91-days they receive access to the 91-day Self-Talk Journal for their own personal use.

Outcome Measures

Primary Outcome Measures

  1. Self-Talk. [Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants]

    Assessed using the Self-Talk Scale. The scale consists of 16 items rated on a five-point frequency scale (1 = never, 5 = very often) using the common stem "I talk to myself when…" It has a four factor-structure comprised of self-assessment, self-reinforcement, self-criticism and self-management. Total scores range from 16-80. Individual subscales scores range from 16-20. The higher the score the greater frequency of one's self-talk.

Secondary Outcome Measures

  1. Self-esteem [Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants]

    Assessed using the Rosenberg Self-Esteem Scale, a 10-item measure of global self-esteem or self-worth. Uses a 4-point likert scale ranging from 1 (strongly agree) to 4 (strongly disagree) Possible scores range from 10-40, higher scores indicate higher levels of self-esteem

  2. Self-consciousness [Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants]

    Aspects of self-consciousness, including private self-consciousness, internal state awareness, self-reflection, public self-consciousness, and social anxiety, will be assessed using the Fenigstein Self-Consciousness Scale. The scale consists of 23 items, rated using a 5-point likert scale ranging from 0 (extremely uncharacteristic) to 4 (extremely characteristic), with higher scores denoting higher levels of self-consciousness.

  3. Automatic Negative Self-Statements [Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants]

    The frequency of automatic negative self-statements will be assessed using the Automatic Thoughts Questionnaire, whose 30-items assess the frequency of negative self-statements associated with depression. Uses a 5-point likert scale comprised of the following: 1 = not at all, 2 = sometimes, 3 = moderately often, 4 = often , and 5 = all of the time. Possible scores range from 30-150, with higher scores indicating greater rates of negative self-statements.

  4. Adherence to Journal [Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants]

    Adherence to the journal for the intervention group will be assessed using three items: "Currently, what is the last day of the journal [the participant] completed?": possible score range 0-91, 0 indicates no days have been completed "[Has the participant] skipped or not completed any days prior to the latest day [the participant] completed?": No or yes - indicate which days "Approximately how many minutes [did the participant] spend completing a day, within the journal?": self-reported number of daily minutes

  5. Experience using the journal. [At 3 months from baseline or if and when intervention participants drop out of the study]

    Intervention group participants' experience using the journal will be assessed through a qualitative exit interview

  6. Demographics [Baseline]

    Age, preferred gender, socio-economic status, ethnicity, educational attainment, and employment status will be collected

  7. Mental Health [Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants]

    Depression and anxiety will be assessed using the Hospital Anxiety and Depression Scale. Possible scores for each subscale range from 0-21. A score of 0-7 = "normal", 8-10 = "Borderline abnormal (borderline case)" and 11-21 = "Abnormal (case)."

  8. Subjective Well-Being [Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants]

    Subjective well-being will be assessed using the Warwick-Edinburgh Mental Wellbeing Scale. Uses a 5-point Likert scale: 1= none of the time, 2= rarely, 3 = some of the time, 4 = often, and 5 = all of the time. Possible scores range from 14 to 70, with higher scores indicating greater mental-wellbeing

  9. Physical Activity, Sedentary Behaviour and Sleep [Change from baseline at 2 weeks, 1 month , 2 months, and 3 months for all participants. As well as 4 months for intervention participants]

    Modified International Physical Activity Questionnaire includes open-ended questions surrounding individuals': Physical activity. Frequency score ranging from 0-7 days per week. Average time spent on one of those days ranging from 0-24 total hours. Separate questions for vigorous intensity, moderate intensity, mild intensity and walking. Sitting reported in average hours per day ranging from 0-24 total hours. Occupational and recreational screentime. Reported using a separate daily average for weekdays and weekends ranging from 0-24 total hours. Sleep reported using average number of hours per night ranging from 0-24 total hours.

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

(1) being 18+ years old, (2) being fluent in English, (3) currently living in the Greater Victoria area, (4) self-reporting no previously diagnosed mental illness or psychiatric conditions, and (5) scoring >12 on the Self-Criticism subscale of the Self-Talk Scale (based on previous mean data; Brinthaupt, Hein, & Kramer, 2009).

Exclusion Criteria:
  • Scoring =<12 on the Self-Talk Scale, currently receiving or seeking therapy for a mental illness, or a current or previous diagnosis of mental illness.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Behavioural Medicine Lab UVic Victoria British Columbia Canada V8p5C2

Sponsors and Collaborators

  • University of Victoria
  • Switch Research
  • Mathematics of Information Technology and Complex Systems

Investigators

  • Principal Investigator: Ryan Rhodes, PhD, Lab Director and Professor

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Victoria
ClinicalTrials.gov Identifier:
NCT05738109
Other Study ID Numbers:
  • 21-0361
First Posted:
Feb 21, 2023
Last Update Posted:
Feb 21, 2023
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Victoria

Study Results

No Results Posted as of Feb 21, 2023